Split cord malformation type I

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1671OMIM:222500Q06.2
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Split cord malformation type I (SCM type I), also known as diastematomyelia type I, is a rare congenital spinal dysraphism in which the spinal cord is divided into two hemicords by a rigid osseocartilaginous (bony or cartilaginous) septum or spur. Each hemicord is contained within its own separate dural tube. This distinguishes it from type II split cord malformation, where the two hemicords share a single dural sac and are separated by a fibrous septum. The condition results from a developmental defect during embryogenesis, likely related to abnormal formation of the notochord and persistence of an accessory neurenteric canal. Split cord malformation type I primarily affects the nervous system and musculoskeletal system. The bony septum tethers the spinal cord, leading to progressive neurological deterioration as the child grows. Key clinical features include lower limb weakness or asymmetry, foot deformities (such as clubfoot), gait abnormalities, back pain, scoliosis, and neurogenic bladder or bowel dysfunction. Cutaneous stigmata overlying the affected spinal segment — such as a hairy patch (hypertrichosis), dimple, lipoma, or hemangioma — are frequently present and may serve as early diagnostic clues. Symptoms may present in infancy or childhood but can occasionally remain undiagnosed until adulthood if neurological deficits are mild. Diagnosis is typically confirmed through MRI of the spine, often supplemented by CT scanning to visualize the bony septum. Treatment is surgical and involves removal of the osseocartilaginous septum and untethering of the spinal cord to prevent further neurological deterioration. Early surgical intervention generally yields better outcomes, particularly in preserving neurological and urological function. Postoperative monitoring is important, as re-tethering can occur. There is no cure for existing neurological damage, and rehabilitation including physiotherapy and management of bladder dysfunction may be necessary as part of long-term care.

Also known as:

Clinical phenotype terms— hover any for plain English:

DiastomatomyeliaHP:0100563
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Split cord malformation type I.

View clinical trials →

No actively recruiting trials found for Split cord malformation type I at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Split cord malformation type I community →

No specialists are currently listed for Split cord malformation type I.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Split cord malformation type I.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Split cord malformation type IForum →

No community posts yet. Be the first to share your experience with Split cord malformation type I.

Start the conversation →

Latest news about Split cord malformation type I

No recent news articles for Split cord malformation type I.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Split cord malformation type I

What is Split cord malformation type I?

Split cord malformation type I (SCM type I), also known as diastematomyelia type I, is a rare congenital spinal dysraphism in which the spinal cord is divided into two hemicords by a rigid osseocartilaginous (bony or cartilaginous) septum or spur. Each hemicord is contained within its own separate dural tube. This distinguishes it from type II split cord malformation, where the two hemicords share a single dural sac and are separated by a fibrous septum. The condition results from a developmental defect during embryogenesis, likely related to abnormal formation of the notochord and persistence

How is Split cord malformation type I inherited?

Split cord malformation type I follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.